View, Inc.

2023 Q4 Form 10-Q Financial Statement

#000181185623000052 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.62M $51.27M
YoY Change -1.28% -86.26%
Cash & Equivalents $50.62M $27.92M
Short-Term Investments $0.00
Other Short-Term Assets $28.60M $19.93M
YoY Change 43.51% 71.18%
Inventory $16.70M $17.85M
Prepaid Expenses
Receivables $42.57M $38.53M
Other Receivables $0.00 $0.00
Total Short-Term Assets $158.8M $127.6M
YoY Change 24.49% -69.17%
LONG-TERM ASSETS
Property, Plant & Equipment $81.46M $281.7M
YoY Change -71.08% 9.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.46M $43.53M
YoY Change -41.51% 251.79%
Total Long-Term Assets $132.6M $325.3M
YoY Change -59.24% 13.67%
TOTAL ASSETS
Total Short-Term Assets $158.8M $127.6M
Total Long-Term Assets $132.6M $325.3M
Total Assets $291.4M $452.9M
YoY Change -35.66% -35.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.23M $15.23M
YoY Change -32.83% 22.61%
Accrued Expenses $57.21M $66.21M
YoY Change -13.6% 30.56%
Deferred Revenue $11.28M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.470M
YoY Change
Total Short-Term Liabilities $87.27M $89.12M
YoY Change -2.08% 7.95%
LONG-TERM LIABILITIES
Long-Term Debt $208.3M $13.23M
YoY Change 1475.28% -10.0%
Other Long-Term Liabilities $17.46M $62.81M
YoY Change -72.21% 10.99%
Total Long-Term Liabilities $225.8M $76.04M
YoY Change 196.94% 6.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $87.27M $89.12M
Total Long-Term Liabilities $225.8M $76.04M
Total Liabilities $359.4M $165.2M
YoY Change 117.59% -1.21%
SHAREHOLDERS EQUITY
Retained Earnings -$2.931B
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$67.94M $287.8M
YoY Change
Total Liabilities & Shareholders Equity $291.4M $452.9M
YoY Change -35.66% -35.3%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18515000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72410000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9799000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9199000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
112507000 usd
CY2022Q4 view Sponsor Earnout Liability Non Current
SponsorEarnoutLiabilityNonCurrent
506000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17458000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
359376000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4053580 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4053580 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-67289000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001811856
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
102284000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42571000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42407000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
15000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
588.42
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0167
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0167
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0167
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0167
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0167
CY2021Q2 view Financing Receivable Non Interest Bearing Period
FinancingReceivableNonInterestBearingPeriod
P31M
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39470
dei Entity Registrant Name
EntityRegistrantName
VIEW, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3235065
dei Entity Address Address Line1
EntityAddressAddressLine1
195 South Milpitas Blvd
dei Entity Address City Or Town
EntityAddressCityOrTown
Milpitas
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95035
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
263-9200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4067035 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50618000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95858000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
20384000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
14587000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
16699000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
17373000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
14000000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1859000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14560000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21851000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
158832000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
296219000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81462000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
262360000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
726000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
16448000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18957000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18485000 usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
6000000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
6999000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
25461000 usd
CY2023Q3 us-gaap Assets
Assets
291438000 usd
CY2022Q4 us-gaap Assets
Assets
619026000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10232000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21099000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57209000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8544000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
11284000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
87269000 usd
CY2023Q3 view Sponsor Earnout Liability Non Current
SponsorEarnoutLiabilityNonCurrent
0 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19329000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19589000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
26989000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
29337000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17758000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
398534000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3695598 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3695598 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2863177000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2814912000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2931115000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2594420000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-67938000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
220492000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
291438000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
619026000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38220000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23762000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84602000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57090000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42573000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49126000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
124596000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
129219000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-4353000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-25364000 usd
us-gaap Gross Profit
GrossProfit
-39994000 usd
us-gaap Gross Profit
GrossProfit
-72129000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8918000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15554000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31573000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56157000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25518000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41174000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74429000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124888000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
170300000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
174300000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
-662000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
4845000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
204074000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
56728000 usd
us-gaap Costs And Expenses
CostsAndExpenses
285147000 usd
us-gaap Costs And Expenses
CostsAndExpenses
181045000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-208427000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-82092000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-325141000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-253174000 usd
CY2023Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-4399000 usd
CY2022Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-58000 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-11530000 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-324000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-158000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-118000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-439000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-259000 usd
CY2023Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0 usd
CY2022Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
226000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
513000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
6511000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4557000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
50000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11456000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5928000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-212984000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82042000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-336597000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-247246000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
77000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-213046000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-213046000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-82065000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-82065000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-336695000 usd
us-gaap Net Income Loss
NetIncomeLoss
-336695000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-247323000 usd
us-gaap Net Income Loss
NetIncomeLoss
-247323000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-53.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-53.06
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-22.93
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-22.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-84.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-84.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-69.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-69.21
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4015307 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4015307 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3579584 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3579584 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3982824 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3982824 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3573700 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3573700 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
220492000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1001000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
17828000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10962000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
180992000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
293000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10530000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-56360000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
134869000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
142000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10381000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-213046000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-67938000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
479338000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17468000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-82372000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
414434000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18141000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-82886000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
349689000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3076000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23226000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-82065000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
287774000 usd
us-gaap Net Income Loss
NetIncomeLoss
-336695000 usd
us-gaap Net Income Loss
NetIncomeLoss
-247323000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16472000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17797000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
513000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
6511000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
32562000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
58835000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
14126000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
174300000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2639000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1008000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
890000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6693000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-674000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7585000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1864000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11090000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
10576000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2616000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-7131000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2803000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2084000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3783000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1255000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1922000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-23536000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-13977000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-139603000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-204201000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7510000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14396000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
106032000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
210133000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 usd
us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
3001000 usd
us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
5160000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
93590000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19556000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
228000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
735000 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
735000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
409000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
400000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1436000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3076000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2808000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4211000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-48821000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-227968000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114165000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297543000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65344000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69575000 usd
us-gaap Interest Paid Net
InterestPaidNet
155000 usd
us-gaap Interest Paid Net
InterestPaidNet
55000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
265000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1569000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2624000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Stock Issued1
StockIssued1
3513000 usd
us-gaap Stock Issued1
StockIssued1
6651000 usd
view Stock Issued From Conversion Of Convertible Notes
StockIssuedFromConversionOfConvertibleNotes
18000000 usd
view Stock Issued From Conversion Of Convertible Notes
StockIssuedFromConversionOfConvertibleNotes
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-336700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-139600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-247300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-204200000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50600000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are almost entirely held by domestic financial institutions with high credit standings. Such deposits may, at times, exceed federally insured limits. As of September 30, 2023, the Company has not experienced any losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2023, four customers represented greater than 10.0% of total revenue, accounting for 22.8%, 17.1%, 11.6% and 10.9% of total revenue, respectively. For the nine months ended September 30, 2022, two customers represented greater than 10.0% of total revenue, accounting for 16.2% and 15.5% of total revenue, respectively. Three customers accounted for 49.2% of accounts receivable, net as of September 30, 2023, accounting for 26.4%, 12.7% and 10.0%, respectively. Two customers accounted for 27.3% of accounts receivable, net as of December 31, 2022, accounting for 17.3% and 10.0%, respectively. Accounts receivable are stated at the amount the Company expects to collect. The Company generally does not require collateral or other security in support of accounts receivable. To reduce credit risk, management performs ongoing credit evaluations of its customers’ financial condition.</span></div>Certain materials used by the Company in the manufacturing of its products are purchased from a limited number of suppliers. Should any such supplier cease to manufacture the products the Company purchases from them or become unable to timely deliver these products in accordance with the Company’s requirements or should such suppliers choose not to do business with the Company, it may be required to locate alternative suppliers in the open market. There can be no assurance that the Company would be able to identify new suppliers with which to do business on terms acceptable to the Company, or at all.
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38220000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23762000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84602000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57090000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38220000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23762000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84602000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57090000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38220000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23762000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84602000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57090000 usd
CY2023Q3 view Contract With Customer Increase Decrease In Contract Loss Accrual
ContractWithCustomerIncreaseDecreaseInContractLossAccrual
200000 usd
CY2022Q3 view Contract With Customer Increase Decrease In Contract Loss Accrual
ContractWithCustomerIncreaseDecreaseInContractLossAccrual
1500000 usd
CY2023Q3 view Contract With Customer Contract Loss Accrual Recognized
ContractWithCustomerContractLossAccrualRecognized
5300000 usd
CY2022Q3 view Contract With Customer Contract Loss Accrual Recognized
ContractWithCustomerContractLossAccrualRecognized
4200000 usd
view Contract With Customer Increase Decrease In Contract Loss Accrual
ContractWithCustomerIncreaseDecreaseInContractLossAccrual
1800000 usd
view Contract With Customer Increase Decrease In Contract Loss Accrual
ContractWithCustomerIncreaseDecreaseInContractLossAccrual
4000000 usd
view Contract With Customer Contract Loss Accrual Recognized
ContractWithCustomerContractLossAccrualRecognized
13500000 usd
view Contract With Customer Contract Loss Accrual Recognized
ContractWithCustomerContractLossAccrualRecognized
12300000 usd
CY2023Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
0 usd
CY2022Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
600000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-3800000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
1400000 usd
CY2023Q3 view Revenue Remaining Performance Obligation Provision For Loss
RevenueRemainingPerformanceObligationProvisionForLoss
7100000 usd
CY2022Q4 view Revenue Remaining Performance Obligation Provision For Loss
RevenueRemainingPerformanceObligationProvisionForLoss
15000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6100000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
20400000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
14600000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1200000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
700000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6300000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1300000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5500000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
32315000 usd
CY2023Q3 view Certificates Of Deposit Fair Value Disclosure
CertificatesOfDepositFairValueDisclosure
14726000 usd
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
47041000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
66614000 usd
CY2022Q4 view Certificates Of Deposit Fair Value Disclosure
CertificatesOfDepositFairValueDisclosure
18308000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
102284000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
187206000 usd
CY2022Q4 view Sponsor Earn Out Liability Fair Value Disclosure
SponsorEarnOutLiabilityFairValueDisclosure
506000 usd
CY2022Q4 view Private Warrants Liability Fair Value Disclosure
PrivateWarrantsLiabilityFairValueDisclosure
7000 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
513000 usd
CY2023Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0 usd
CY2022Q3 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
226000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
513000 usd
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
6511000 usd
CY2021Q1 view Earn Out Shares Subject To Vesting And Potential Forfeiture
EarnOutSharesSubjectToVestingAndPotentialForfeiture
82835 shares
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
3991000 usd
CY2022 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
2004000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4312000 usd
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6313000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
40934000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
39573000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
10236000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
8868000 usd
CY2023Q3 us-gaap Cash
Cash
18303000 usd
CY2022Q4 us-gaap Cash
Cash
29244000 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
32315000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
66614000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50618000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
95858000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
14000000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1859000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
726000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
16448000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65344000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114165000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLossCurrent
102284000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
102284000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
700000 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
700000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
700000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1800000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
29337000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
33388000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
13945000 usd
us-gaap Inventory Write Down
InventoryWriteDown
8400000 usd
us-gaap Inventory Write Down
InventoryWriteDown
14200000 usd
CY2021Q2 view Financing Receivable Annual Interest Rate Increase31 Months Following Advance
FinancingReceivableAnnualInterestRateIncrease31MonthsFollowingAdvance
0.035
CY2023Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4000000 usd
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0 usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
6000000 usd
CY2023Q3 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
170000000 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
170000000 usd
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13945000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
10236000 usd
CY2023Q3 view Contract With Customer Contract Loss Accrual Current
ContractWithCustomerContractLossAccrualCurrent
6842000 usd
CY2022Q4 view Contract With Customer Contract Loss Accrual Current
ContractWithCustomerContractLossAccrualCurrent
12848000 usd
CY2023Q3 view Accrual For Environmental Settlement Current
AccrualForEnvironmentalSettlementCurrent
1000000 usd
CY2022Q4 view Accrual For Environmental Settlement Current
AccrualForEnvironmentalSettlementCurrent
1450000 usd
CY2023Q3 view Lease Liability Current
LeaseLiabilityCurrent
3733000 usd
CY2022Q4 view Lease Liability Current
LeaseLiabilityCurrent
3949000 usd
CY2023Q3 view Vendor Accrual Current
VendorAccrualCurrent
16312000 usd
CY2022Q4 view Vendor Accrual Current
VendorAccrualCurrent
18435000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15377000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25492000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57209000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72410000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
39573000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
42256000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1682000 usd
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1626000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
10236000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
26989000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
29337000 usd
CY2014Q4 view Litigation Settlement With Third Party
LitigationSettlementWithThirdParty
32000000 usd
CY2014Q4 view Periodic Payment Term Litigation Settlement
PeriodicPaymentTermLitigationSettlement
P10Y
CY2023Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
3000000 usd
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
3000000 usd
CY2023Q3 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
3332000 usd
CY2022Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
5794000 usd
CY2023Q3 us-gaap Litigation Reserve
LitigationReserve
6332000 usd
CY2022Q4 us-gaap Litigation Reserve
LitigationReserve
8794000 usd
CY2023Q3 view Accrual For Environmental Settlement Current
AccrualForEnvironmentalSettlementCurrent
1000000 usd
CY2022Q4 view Accrual For Environmental Settlement Current
AccrualForEnvironmentalSettlementCurrent
1450000 usd
CY2023Q3 view Accrual For Environmental Settlement Non Current
AccrualForEnvironmentalSettlementNonCurrent
1000000 usd
CY2022Q4 view Accrual For Environmental Settlement Non Current
AccrualForEnvironmentalSettlementNonCurrent
3000000 usd
CY2023Q3 view Accrual For Environmental Settlement
AccrualForEnvironmentalSettlement
2000000 usd
CY2022Q4 view Accrual For Environmental Settlement
AccrualForEnvironmentalSettlement
4450000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
209801000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
220307000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1470000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1470000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
208331000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
218837000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
735000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1470000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1470000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1470000 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
198046000 usd
CY2023Q3 view Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
6610000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
209801000 usd
CY2022Q4 view Blocker Agreement Increase Decrease In Ownership Percentage Days Of Prior Written Notice Required
BlockerAgreementIncreaseDecreaseInOwnershipPercentageDaysOfPriorWrittenNoticeRequired
P61D
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 view Debt Instrument Covenant Number Of Days Audited Financials Are To Be Delivered To Lender
DebtInstrumentCovenantNumberOfDaysAuditedFinancialsAreToBeDeliveredToLender
210 day
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4053580 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4053580 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
14035 shares
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 usd
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
49389 shares
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1400000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3100000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3100000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q3 view Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
158518 shares
CY2022Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
158518 shares
CY2023Q3 view Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2023Q3 view Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
38 shares
view Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
3509 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
509233 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
512742 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
400000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
567.23
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
385000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
566.06
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
386000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
566.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y4M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
365000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
564.20
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M12D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q3 us-gaap Share Price
SharePrice
7.51
CY2022Q4 us-gaap Share Price
SharePrice
57.90
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3800000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
22300000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5300000 usd
view Employee Service Share Based Compensation Nonvested Awards Total Compensation Expected To Be Recognized Weighted Average Service Period
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationExpectedToBeRecognizedWeightedAverageServicePeriod
P1Y4M24D
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10610000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23226000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32562000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
58835000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
4200000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
1300000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
-700000 usd
CY2023Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
2900000 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
600000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
-700000 usd
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
100000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 usd
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-213046000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-82065000 usd
us-gaap Net Income Loss
NetIncomeLoss
-336695000 usd
us-gaap Net Income Loss
NetIncomeLoss
-247323000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4015307 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4015307 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3579584 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3579584 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3982824 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3982824 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3573700 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3573700 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-53.06
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-53.06
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-22.93
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-22.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-84.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-84.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-69.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-69.21
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2579277 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
869585 shares
CY2023Q3 view Earn Out Shares Subject To Vesting And Potential Forfeiture
EarnOutSharesSubjectToVestingAndPotentialForfeiture
82835 shares

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
view-20230930_cal.xml Edgar Link unprocessable
0001811856-23-000052-index-headers.html Edgar Link pending
0001811856-23-000052-index.html Edgar Link pending
0001811856-23-000052.txt Edgar Link pending
0001811856-23-000052-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
view-20230930.htm Edgar Link pending
view-20230930.xsd Edgar Link pending
view-20230930x10qex101.htm Edgar Link pending
view-20230930x10qex311.htm Edgar Link pending
view-20230930x10qex312.htm Edgar Link pending
view-20230930x10qex321.htm Edgar Link pending
view-20230930x10qex322.htm Edgar Link pending
view-20230930_def.xml Edgar Link unprocessable
view-20230930_pre.xml Edgar Link unprocessable
view-20230930_lab.xml Edgar Link unprocessable
view-20230930_htm.xml Edgar Link completed